AMGN - Amgen Inc
Earnings Results

Amgen Inc ( $AMGN )

Recent earnings result

  1. Amgen EPS beats by $0.45, beats on revenue

Top Stories (AMGN)

Events & Annual meetings

Title Date Webcast
Amgen Announces BLINCYTO® (blinatumomab) Five-Year Overall Survival Data At EHA 2019 06/16/19
FDA Approves Amgen And Allergan's KANJINTI™ (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab) 06/13/19
Intermountain Healthcare and deCODE genetics Launch Groundbreaking DNA Study of 500,000 People to Find New Links Between Genetics and Disease 06/12/19
Amgen Publishes Offer Document With Respect To The Recommended Public Cash Offer To The Shareholders Of Nuevolution 06/12/19
Amgen To Present At The Goldman Sachs 40th Annual Global Healthcare Conference 06/07/19





Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.


Videos about Amgen Inc

Disclaimer:

The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

Recent results

Books we are reading